EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark RESVIVAX was filed as Word mark on 02/15/2021 at the European Union Intellectual Property Office.
It was registered as a trademark on 03/18/2021.
The current status of the mark is "Registration cancelled".
| Trademark form | Word mark |
| File reference | 018399175 |
| Application date | February 15, 2021 |
| Publication date | March 22, 2021 |
| Entry date | March 18, 2021 |
| Expiration date | February 15, 2031 |
Trademark owner
21 Firstfield Road
20878 Gaithersburg
US
20878 Gaithersburg
US
Trademark representatives
Herwarthstr. 1
50672 Köln
DE
goods and services
5
Vaccines; vaccine adjuvants
42
Pharmaceutical, biologic, and vaccine research and development; consulting services in the field of research and development of pharmaceutical, biologic, and vaccine preparations and adjuvants; providing medical and scientific research information in the field of pharmaceuticals, biologics, and vaccines
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| May 3, 2024 | Decision on opposition, Published | ||
| April 28, 2024 | RAW: Cancellation - Total Cancellation, Totally cancelled | ||
| March 28, 2024 | Change Representative, Published | ||
| March 7, 2022 | appealed, Published | ||
| January 4, 2022 | Change Representative, Published | ||
| October 14, 2021 | Change Representative, Published |
ID: 11018399175